Back to results
RecruitingPhase 2

Genomic and Transcriptomic Predictors of Sequential SG Sensitivity After T-DXd in ER+/HER2-Low Metastatic Breast Cancer

NCT06665178

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

BC Cancer - Vancouver Center

Vancouver, British Columbia, Canada

Contact

Stephen Chia, MD

604-877-6000schia@bccancer.bc.ca
View on ClinicalTrials.gov
Genomic and Transcriptomic Predictors of Sequential SG Sensitivity After T-DXd in ER+/HER2-Low Metastatic Breast Cancer — TrialFind